Gateways to clinical trials . Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses . The data in the following tables has been retrieved from the Clinical Studies Knowledge Area of Prous Science Integrity(R) , the drug discovery and development portal , http://integrity.prous.com . This issue focuses on the following selection of drugs : 3,4-DAP ; DB00718 , Q16586 -10-0101 , alefacept , alemtuzumab , alosetron hydrochloride , ALT-711 , aprepitant , atazanavir sulfate , atlizumab , atvogen ; DB00188 ; P11597 vaccine , clevudine , crofelemer ; P22760 : P0C6A0 , darbepoetin alfa , decitabine , drotrecogin alfa ( activated ) , DX-9065a ; E-7010 , edodekin alfa , emivirine , emtricitabine , entecavir , erlosamide , erlotinib hydrochloride , everolimus , exenatide ; DB00569 , frovatriptan , fulvestrant ; DB00056 , gestodene ; DB04865 , human insulin ; Imatinib mesylate , indiplon , indium 111 ( 111In ) ibritumomab tiuxetan , inhaled insulin , insulin detemir , insulin glargine , ivabradine hydrochloride ; DB06792 , lapatinib , O43766 -34475 , levetiracetam , liraglutide , lumiracoxib ; Maxacalcitol , melagatran , micafungin sodium ; DB00108 , NSC-640488 ; Oblimersen sodium ; DB08439 sodium , PEG-filgrastim , peginterferon alfa-2(a) , peginterferon alfa-2b , pexelizumab , pimecrolimus , pleconaril , pramlintide acetate , pregabalin , prucalopride ; DB00025 -PFM , Ranelic acid distrontium salt , ranolazine , rDNA insulin , recombinant human soluble thrombomodulin , rhGM- P04141 , roxifiban acetate , RSD-1235 , rubitecan , ruboxistaurin mesilate hydrate ; SC-51 , squalamine ; DB01079 maleate , telbivudine , tesaglitazar , testosterone gel , tezosentan disodium , tipranavir ; DB04879 succinate ; DB04898 ; Yttrium 90 ( 90Y ) ibritumomab tiuxetan ; DB00399 monohydrate .